Mien-Chie Hung

Mien-Chie Hung

China Medical University

H-index: 169

Asia-China

About Mien-Chie Hung

Mien-Chie Hung, With an exceptional h-index of 169 and a recent h-index of 97 (since 2020), a distinguished researcher at China Medical University, specializes in the field of Immunotherapy, Target Therapy, Cross talk and Drug Resistance, Breast and GI Cancers.

His recent articles reflect a diverse array of research interests and contributions to the field:

BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers

Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy

Revitalizing CAR-T cells for TNBC: Targeting phosphorylation of TCF7 to overcome T cell exhaustion

MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer

Article Genetic insights into carbohydrate sulfotransferase 8 and its impact on the of cancer

Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer

Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancer

Mien-Chie Hung Information

University

Position

___

Citations(all)

104732

Citations(since 2020)

34966

Cited By

82198

hIndex(all)

169

hIndex(since 2020)

97

i10Index(all)

671

i10Index(since 2020)

439

Email

University Profile Page

China Medical University

Google Scholar

View Google Scholar Profile

Mien-Chie Hung Skills & Research Interests

Immunotherapy

Target Therapy

Cross talk and Drug Resistance

Breast and GI Cancers

Top articles of Mien-Chie Hung

Title

Journal

Author(s)

Publication Date

BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers

Cancer Discovery

Guang Lei

Chao Mao

Amber D Horbath

Yuelong Yan

Shirong Cai

...

2024/3/28

Gasdermin C sensitizes tumor cells to PARP inhibitor therapy in cancer models

The Journal of Clinical Investigation

Shuanglian Wang

Chiung-Wen Chang

Juan Huang

Shan Zeng

Xin Zhang

...

2024/1/2

Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy

Nature Cancer

Yu-Kai Huang

Wei-Chung Cheng

Ting-Ting Kuo

Juan-Cheng Yang

Yang-Chang Wu

...

2024/1/24

Revitalizing CAR-T cells for TNBC: Targeting phosphorylation of TCF7 to overcome T cell exhaustion

Cancer Research

Zhou Jiang

Yu-Yi Chu

Heng-Huan Lee

Mien-Chie Hung

Liuqing Yang

...

2024/3/22

MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer

International Journal of Biological Sciences

Hirohito Yamaguchi

Ling-Chu Chang

Olin Shih-Shin Chang

Yu-Fu Chen

Yu-Chun Hsiao

...

2024

Article Genetic insights into carbohydrate sulfotransferase 8 and its impact on the of cancer

CELL REPORTS

Wen-Cheng Chou

Wei-Ting Chen

Chun-Tse Kuo

Yao-Ming Chang

Yen-Shen Lu

...

2024/1/23

Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer

Parham Jabbarzadeh Kaboli

Hsiao-Fan Chen

Ali Babaeizad

Kiarash Roustai Geraylow

Hirohito Yamaguchi

...

2024/3/8

Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancer

Cell Reports

Wen-Cheng Chou

Wei-Ting Chen

Chun-Tse Kuo

Yao-Ming Chang

Yen-Shen Lu

...

2024/1/23

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma

Journal of Hepatology

Peiyi Xie

Mincheng Yu

Bo Zhang

Qiang Yu

Yufei Zhao

...

2024/2/23

Abstract P53: Inhibition of STING/Galectin-9 Axis Sensitize Anthracyclines Treatment And Induce Anti-tumor Immunity

Cancer Research

Xian Sun

Wei-Jan Wang

Jilu Lang

Riyao Yang

Wan-Jou Shen

...

2024/4/15

Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis

Nucleic Acids Research

Hsiao-Fan Chen

Chia-Ting Chang

Kai-Wen Hsu

Pei-Hua Peng

Joseph Chieh-Yu Lai

...

2024/1/11

TAG Synthesis and Oxidation Activated by YAP/TEAD Confers ROS Resistance in Cancer Stem Cells

Jiun-Han Lin

Tien-Wei Hsu

Wei-Chung Cheng

Chen-Chi Liu

Anna Fen-Yau Li

...

2024/2/12

Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer

Nature Communications

Jie Fu

Jianhua Ling

Ching-Fei Li

Chi-Lin Tsai

Wenjuan Yin

...

2024/4/11

Method for treating lung cancer

2024/1/4

Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma

Nature Communications

Chunxiao Liu

Chenhao Zhou

Weiya Xia

Yifan Zhou

Yufan Qiu

...

2024/2/2

Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation

Nature Communications

An Xu

Mo Liu

Mo-Fan Huang

Yang Zhang

Ruifeng Hu

...

2023/3/27

Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof

2023/5/30

The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2

eLife

Hsiao-Fan Chen

Wei-Jan Wang

Chung-Yu Chen

Wei-Chao Chang

Po-Ren Hsueh

...

2023/8/29

Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry

Biomedicines

Shaneek Natoya Dabrell

Yi-Chuan Li

Hirohito Yamaguchi

Hsiao-Fan Chen

Mien-Chie Hung

2023/10/27

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

International Journal of Biological Sciences

Xian Sun

Wei-Jan Wang

Jilu Lang

Riyao Yang

Wan-Jou Shen

...

2023

See List of Professors in Mien-Chie Hung University(China Medical University)